RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alpha(v)beta(3)-expressing endothelial cells

Astrid Leegte - Schraa; R.J Kok; S.M. Botter; S Withoff; D.K F Meijer; Lou de Leij; G Molema

doi:10.1002/ijc.20413

RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alpha(v)beta(3)-expressing endothelial cells

Astrid Leegte - Schraa, R.J Kok, S.M. Botter, S Withoff, D.K F Meijer, Lou de Leij, G Molema

Onderzoeksoutput: Article › Academic › peer review

15 Citaten (Scopus)

Originele taal-2	English
Pagina's (van-tot)	279 - 285
Aantal pagina's	7
Tijdschrift	International Journal of Cancer
Volume	112
Nummer van het tijdschrift	2
DOI's	https://doi.org/10.1002/ijc.20413
Status	Published - nov.-2004

Toegang tot document

10.1002/ijc.20413

Handle.net

Permanente koppeling

Citeer dit

@article{7f510584ca7b4242ac92ede4981d0a6a,

title = "RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alpha(v)beta(3)-expressing endothelial cells",

keywords = "immunotherapy, vascular targeting, cytotoxic T lymphocytes, alpha(v)beta(3) integrin, RGD peptide, BISPECIFIC ANTIBODY, TUMOR VASCULATURE, MODIFIED PROTEINS, GROWTH, INTEGRINS, PEPTIDES, CANCER, DELIVERY, THERAPY, VACCINE",

author = "{Leegte - Schraa}, Astrid and R.J Kok and S.M. Botter and S Withoff and Meijer, {D.K F} and {de Leij}, Lou and G Molema",

note = "J Article",

year = "2004",

month = nov,

doi = "10.1002/ijc.20413",

language = "English",

volume = "112",

pages = "279 -- 285",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alpha(v)beta(3)-expressing endothelial cells

AU - Leegte - Schraa, Astrid

AU - Kok, R.J

AU - Botter, S.M.

AU - Withoff, S

AU - Meijer, D.K F

AU - de Leij, Lou

AU - Molema, G

N1 - J Article

PY - 2004/11

Y1 - 2004/11

KW - immunotherapy

KW - vascular targeting

KW - cytotoxic T lymphocytes

KW - alpha(v)beta(3) integrin

KW - RGD peptide

KW - BISPECIFIC ANTIBODY

KW - TUMOR VASCULATURE

KW - MODIFIED PROTEINS

KW - GROWTH

KW - INTEGRINS

KW - PEPTIDES

KW - CANCER

KW - DELIVERY

KW - THERAPY

KW - VACCINE

U2 - 10.1002/ijc.20413

DO - 10.1002/ijc.20413

M3 - Article

SN - 0020-7136

VL - 112

SP - 279

EP - 285

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 2

ER -